EHA 2025

Explore advancements in hematology with the 2025 European Hematology Association Ambassador Program, supported by Novartis Canada. This initiative provides a focused overview of key abstracts and research in Chronic Myeloid Leukemia (CML), Paroxysmal Nocturnal Hemoglobinuria (PNH), and Myeloproliferative Neoplasms (MPNs).